◆BLACKSPECTER AI Chat öffnen →

BlackSpecter›Aktien›GILD

GILD (GILD)

Kennzahlen

Marktkapitalisierung

n/a

KGV (TTM)

n/a

Umsatz (TTM)

n/a

EBITDA

n/a

Dividendenrendite

n/a

52W Hoch

n/a

52W Tief

n/a

Beta

n/a

EPS (TTM)

n/a

Forward KGV

n/a

PEG Ratio

n/a

Short-Quote

n/a

Analysten-Ratings

Keine Analysten-Daten verfügbar

Earnings

Keine Earnings-Daten verfügbar

Aktuelle News

StockStory·vor 19 Std.

Spotting Winners: Gilead Sciences (NASDAQ:GILD) And Therapeutics Stocks In Q1

Trefis·vor 1 Tagen

Own Regeneron For Biotech Growth? Incyte Is Making Its Case.

Motley Fool·vor 2 Tagen

Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.

Zacks·vor 4 Tagen

Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts

Motley Fool·vor 4 Tagen

2 Recession-Resistant Dividend Stocks to Buy and Hold

Simply Wall St.·vor 5 Tagen

Is Gilead Sciences (GILD) Cheap With Trodelvy And Yeztugo In Focus?

Frag BlackSpecter AI über GILD

Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.

Ist GILD kaufenswert?GILD Earnings Analyse GILD Bewertung

AI Chat öffnen →